Search

Home > Hematologic Oncology Update > What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Podcast: Hematologic Oncology Update
Episode:

What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Category: Science & Medicine
Duration: 01:02:43
Publish Date: 2023-09-22 22:29:41
Description: Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma.
Total Play: 0

Users also like

500+ Episodes
Kwik Brain: .. 900+     100+

Some more Podcasts by Dr. Neil Love

500+ Episodes
Breast Cance .. 100+     10+
600+ Episodes
Lung Cancer ..    
300+ Episodes
Gastrointest .. 7     3